Award notice Supplies

Leveren van Pomalidomide - capsule 1 mg; 2 mg; 3 mg; 4 mg

Notice published in Dutch. The AI analysis summarises it for you in your language.

Official notice and documents

Public buyer: UZ Leuven
Leuven
Place of performance: 3000 Leuven, Flemish Brabant
Bids received: 3
Form: Framework agreement
Multi-year contract: the buyer places orders as needs arise.
Procedure: Open procedure
Any company may submit a bid.
Publication: 14 October 2026
Notice language: Dutch

AI analysis: go for it or not?

Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.

Create my free account

Unlimited analyses during the 14-day Pro trial, no card needed.

Description

Leveren van Pomalidomide - capsule 1 mg; 2 mg; 3 mg; 4 mg

CPV codes

European codes that classify what the contract is about. They are how we find the tenders for your trade.

33652000 33600000 33652100 33690000

Winning prices for comparable contracts

A quarter below: €290,000
Median: €403,000
A quarter above: €1,351,075

Amounts awarded (excl. VAT) over the last 3 years for 5 contracts in the same CPV group (3365…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.

Similar contracts already awarded

Contract	Winner	Amount
Immunoglobuline humaine normale pour administration intraveineuse Cliniques universitaires Saint Luc · 22 October 2026	CSL BEHRING	€16,277,080
Antimycotica AZ Delta vzw · 21 October 2026	Arega Pharma NV Sandoz NV Fresenius Kabi NV Pfizer NV	€300,945
Purchase, storage and delivery of live attenuated homologous vaccine against Lumpy Skin Disease European Commission, DG SANTE - Health and Food Safety · 1 October 2026	Huvepharma EOOD	€2,385,950
Raamovereenkomst voor het leveren van immunoglobulines IV 10% Universitair Ziekenhuis Gent · 24 September 2026	CSL BEHRING NV	€27,360,000
Aankoop en levering van plasmaderivaten Algemeen Ziekenhuis Sint-Maria vzw · 15 September 2026	CSL BEHRING DEPARTEMENT CENTRAL DE FRACTIONNEMENT Prothya Biosolutions Netherlands B.V. OCTAPHARMA BENELUX	€18,749,295

Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 709176-2026.